7-[4-(trifluoromethoxy)phenyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one, 97.0%, 5g

3-(tert-Butoxycarbonylamino)pyrrolidinehydrochloride, 95.0%, 10g

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,6-difluorophenyl)propanoic acid, 98%, 1g

3-(4-((2-Aminoethyl)amino)-1,2,5-oxadiazol-3-yl)-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one hydrochloride, 98%, 1g

Methyl Propionate [Standard Material for GC]>99.5%(GC)5mL

N-(Ethoxycarbonyl)-N-(furan-2-ylmethyl)glycine, 95%, 1g

2,3':4',2''-Terthiophene, 95%, 1g

4-Methoxy-3-isopropylbenzoic acid, 98%, 500mg

Benzonitrile, 2-[[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]methyl]-, 95%, 10g

7-methoxy-2,1,3-benzoxadiazole-4-sulfonyl chloride, 95.0%, 1g

Z-Thr-OBzl, 98%, 10g

3-(tert-Butyl)-1-methylpyrazole-5-carbonylchloride, 95.0%, 1g

O-(Propargyl)-N-(triethoxysilylpropyl)carbamate (inhibited with MEHQ), 90%, 250mg